Last Updated 20 October 2021.
4 Vaccines Approved for Use in Republic of Korea
-
Moderna
mRNA-1273- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 76 countries
31 trials in 2 countries
Approval Source: modernatx.gcs-web.com
-
Pfizer/BioNTech
BNT162b2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 103 countries
37 trials in 2 countries
Approval Source: asia.nikkei.com
-
Janssen (Johnson & Johnson)
Ad26.COV2.S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 75 countries
13 trials in 16 countries
Approval Source: mfds.go.kr
-
Oxford/AstraZeneca
AZD1222- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 124 countries
45 trials in 23 countries
Approval Source: reuters.com
7 Vaccines in Clinical Trials in Republic of Korea
-
SK Bioscience Co Ltd
GBP510- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
5 trials in 1 country
-
Genexine
GX-19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
6 trials in 1 country
-
EuBiologics Co Ltd
EuCorVac-19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
GeneOne Life Science Inc
GLS-5310- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Cellid Co
AdCLD-CoV19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
SK Bioscience Co Ltd
NBP2001- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Cellid Co
AdCLD-CoV19-1- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country